Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Aethlon Medical (AEMD) over the last 14 years, with Q1 2025 value amounting to $2192.0.

  • Aethlon Medical's Cash from Investing Activities rose 14467.09% to $2192.0 in Q1 2025 from the same period last year, while for Dec 2024 it was -$7099.0, marking a year-over-year increase of 9724.04%. This contributed to the annual value of -$250867.0 for FY2024, which is 7340.0% up from last year.
  • According to the latest figures from Q1 2025, Aethlon Medical's Cash from Investing Activities is $2192.0, which was up 14467.09% from -$2192.0 recorded in Q4 2024.
  • In the past 5 years, Aethlon Medical's Cash from Investing Activities ranged from a high of $2192.0 in Q1 2025 and a low of -$739165.0 during Q3 2022
  • For the 5-year period, Aethlon Medical's Cash from Investing Activities averaged around -$103228.0, with its median value being -$38374.0 (2021).
  • As far as peak fluctuations go, Aethlon Medical's Cash from Investing Activities plummeted by 394490.57% in 2022, and later surged by 14467.09% in 2025.
  • Aethlon Medical's Cash from Investing Activities (Quarter) stood at -$57934.0 in 2021, then crashed by 161.48% to -$151486.0 in 2022, then skyrocketed by 94.19% to -$8807.0 in 2023, then soared by 75.11% to -$2192.0 in 2024, then surged by 200.0% to $2192.0 in 2025.
  • Its Cash from Investing Activities was $2192.0 in Q1 2025, compared to -$2192.0 in Q4 2024 and -$4907.0 in Q1 2024.